The invention relates to a compound NMNH
calcium salt, in particular to an amorphous form of a reduced beta-
nicotinamide mononucleotide
calcium salt, a preparation method of the reduced beta-
nicotinamide mononucleotide
calcium salt, application of the reduced beta-
nicotinamide mononucleotide calcium salt as a pharmaceutical ingredient, a health care product ingredient, a
cosmetic ingredient or a
food additive, and a preparation containing the reduced beta-
nicotinamide mononucleotide calcium salt, and belongs to the field of medicines, health care products,
cosmetics and food additives. Specifically, the invention describes an amorphous compound of NMNH calcium salt, the compound shows long-term continuous stability, the
oxidation resistance, the stability and the
moisture absorption resistance of the compound are obviously superior to those of NMNH disodium salt, and the compound is more beneficial to long-term storage, popularization and marketing. The preparation process of the NMNH calcium salt amorphous compound is simple, easy to control and suitable for large-scale production.